India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.
NEW ORAL GLP-1 DRUG SHOWS ENCOURAGING RESULTS DURING TRIALS Why in the News? Clinical Breakthrough: The experimental oral GLP-1 drug Elecoglipron showed promising results in reducing blood sugar levels and promoting weight loss in Type-2 diabetes patients. Published Findings: The results were presented at the American Diabetes Association Scientific Sessions and simultaneously published in The …
Read MoreSupreme Court Bars Stem Cell Therapy for Autism Why in the News ? The Supreme Court of India ruled that stem cell therapy cannot be offered as a clinical service for Autism Spectrum Disorder (ASD) due to lack of proven scientific evidence, questioning the Centre’s inaction against clinics promoting unverified “miraculous cures”. Supreme Court’s Key …
Read MoreWhy in the news? A study published in Springer Nature highlights that adolescent girls and individuals with co-morbidities are at increased risk of adverse events after receiving Bharat Biotech’s Covexin (BBV152) vaccine. Nearly one-third of participants in the observational study reported adverse events of special interest (AESI). Conducted by Banaras Hindu University, the study titled …
Read More
